Navigation und Service

Zielgruppeneinstiege

Abstract zur Publikation: A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PCR

Behrendt R, Fiebig U, Norley S, Gürtler L, Kurth R, Denner J (2009): A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PCR.
J. Virol. Methods 159: 40-46.

Specific, effective and rapid neutralization assays are crucial for the development of an HIV vaccine based on the stimulation of neutralizing antibodies and the development of such an assay for thehumanimmunodeficiency virus-2 (HIV-2) is described. Virus neutralization was measured as the reduction of provirus integration using a duplex real-time PCR with high efficiency (99.4%). This PCR uses primers and a probe specific for the proviral LTR. Amplification and quantitative analysis of the cellular GAPDH gene was carried out in parallel to control for toxic or growth-inhibitory components in the sera. The neutralization assaywas used to screen sera from23 HIV-2 infected patients. 21 sera were able to neutralize HIV-260415K, 20 sera neutralized HIV-27312A and 7 sera cross-neutralized HIV-1 IIIB. In contrast, when 14 of these sera were tested in parallel with a conventional neutralization assay based on a p27Gag capture ELISA, only one was found to neutralize HIV-260415K and 11 to neutralize HIV-27312A compared with 12 and 13 sera respectively using the PCR-based assay.

Zusatzinformationen

Gesundheitsmonitoring

In­fek­ti­ons­schutz

Forschung

Kom­mis­sio­nen

Ser­vice

Das Robert Koch-Institut ist ein Bundesinstitut im Geschäftsbereich des Bundesministeriums für Gesundheit

© Robert Koch-Institut

Alle Rechte vorbehalten, soweit nicht ausdrücklich anders vermerkt.